Wildon Farwell
CIK 1847941 · Chief Medical Officer · last filed 2024-08-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.61M
Companies
1
Total Filings
20
Lifetime Open-Market Net
-$955.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DYN | Chief Medical Officer | 143,483 | $18.19 | $2.61M | -$955.5K | 20 | 2024-08-20 |
Recent Filings · Page 2 of 2
20 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-09-13 | DYN | Sell (S) | −1,707 | -$17.8K | EDGAR |
| 2023-06-14 | DYN | Sell (S) | −1,698 | -$21.1K | EDGAR |
| 2023-03-15 | DYN | Sell (S) | −7,441 | -$99.2K | EDGAR |
| 2022-12-13 | DYN | Mixed | +35,372 | -$6.8K | EDGAR |
| 2022-09-15 | DYN | Disp (D) | −658 | -$9.2K | EDGAR |
| 2022-06-15 | DYN | Disp (D) | −668 | -$3.3K | EDGAR |
| 2022-03-14 | DYN | Sell (S) | −640 | -$5.6K | EDGAR |
| 2022-03-03 | DYN | Sell (S) | −5,617 | -$48.1K | EDGAR |
| 2021-12-14 | DYN | Grant (A) | +22,307 | $0 | EDGAR |
| 2021-03-04 | DYN | Grant (A) | +50,000 | $0 | EDGAR |
Showing 11–20 of 20
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.